In 2025, Baheal Pharma Group has been honored with “Top 30 Chinese Strategic Investors/CVC” from Zero2IPO Group

In 2025, Baheal Medical is listed as the Industrial Enterprise of Chinese Pharmaceutical R&D Product Lines from China National Pharmaceutical Industry Information Center

In 2024, Baheal Zhongxin Capital has been honored with the “2024 Top 50 Best Direct Investment Companies in China” by CV Awards.

In 2024, Baheal Medical has been honored with "Golden Bull Award-the Most Valuable Investment Company"

In 2024, Top 50 GEM Listed Companies

In 2024, Top 500 Chinese Service Industry Company in Public Welfare

In 2024, the Chinese Medicine Emerging Innovative Force

In 2024, the Qingdao Model Enterprise

In 2023, the Advanced Group of "Mentougou Model - Pioneer in Floods Resistance"

In 2023, Top 500 Chinese Private Company in Public Welfare